‘Aspen Pharmacare discussed destruction of life-saving drugs to drive up prices'

Aspen Pharmacare had discussed destroying its stockpile of life-saving cancer drugs in order to drive up prices by 4000%, according to a report by The Times of London.

This comes after the JSE-listed pharmaceutical company bought the rights to five cancer drugs from GlaxoSmithKline.

The company [Aspen Pharmacare] would have enjoyed a monopoly in the marketplace and was no doubt tempted to use its newly gained power to exploit its customers and reap fabulous returns for its shareholders...

Rob Worthington-Smith, FarSightFirms

FarSightFirms rates the maturity of a company’s leadership based on how it responds to material non-financial issues (material to the medium- to long-term financial sustainability of the company).

It did extensive research into Aspen Pharmacare.

The drug maker also failed to disclose its 2016 €5.2-million Italian competition authority fine for price gouging.

Is Aspen Pharmacare morally bankrupt?

The Money Show’s Bruce Whitfield interviewed Worthington-Smith.

Although Aspen Pharmacare Chairperson Kuseni Dlamini was scheduled to talk to Whitfield he decided not to come on the show when he heard what the topic of conversation was.

Listen to the interview in the audio below (and/or scroll down for quotes from it).

They [Aspen Pharmacare] make fluffy statements about caring for customers…

Rob Worthington-Smith, FarSightFirms

You can’t be cheating the marketplace.

Rob Worthington-Smith, FarSightFirms

There isn’t evidence of a moral code.

Rob Worthington-Smith, FarSightFirms

It’s important that companies stand for something.

Rob Worthington-Smith, FarSightFirms

I’d love to think Aspen Pharmacare has a communication problem [instead of an ethics one].

Rob Worthington-Smith, FarSightFirms

Click here (then“like” the page) to follow Bruce on Facebook.

Enter your email address in the form below to receive a newsletter containing the most-read articles of the week from Bruce Whitfield’s The Money Show every Friday morning in your inbox.

Subscribe to our Business Wrap Newsletter

Article brought to us by Old Mutual.


This article first appeared on 702 : ‘Aspen Pharmacare discussed destruction of life-saving drugs to drive up prices'


CapeTalk welcomes all comments that are constructive, contribute to discussions in a meaningful manner and take stories forward.

However, we will NOT condone the following:

  • Racism (including offensive comments based on ethnicity and nationality)
  • Sexism
  • Homophobia
  • Religious intolerance
  • Cyber bullying
  • Hate speech
  • Derogatory language
  • Comments inciting violence.

We ask that your comments remain relevant to the articles they appear on and do not include general banter or conversation as this dilutes the effectiveness of the comments section.

We strive to make the CapeTalk community a safe and welcoming space for all.

CapeTalk reserves the right to: 1) remove any comments that do not follow the above guidelines; and, 2) ban users who repeatedly infringe the rules.

Should you find any comments upsetting or offensive you can also flag them and we will assess it against our guidelines.

CapeTalk is constantly reviewing its comments policy in order to create an environment conducive to constructive conversations.

Read More
Sibanye-Stillwater to buy Lonmin

Sibanye-Stillwater to buy Lonmin

The Money Show’s Bruce Whitfield interviews Sibanye-Stillwater Chief Executive Officer Neal Froneman.

Fund manager lays criminal charges against former Steinhoff CEO Markus Jooste

Fund manager lays criminal charges against former Steinhoff CEO Markus Jooste

The Money Show’s Bruce Whitfield interviews Benguela Global Fund Managers Chief Investment Officer Zwelakhe Mnguni.

Trends that’ll dominate the business environment in 2018

Trends that’ll dominate the business environment in 2018

It’s time to start thinking about how to keep your business relevant next year, says small business guru Pavlo Phitidis.

What you must learn from the Steinhoff and EOH share price collapses

What you must learn from the Steinhoff and EOH share price collapses

The Money Show’s Bruce Whitfield interviews Galileo Capital Personal Financial Advisor Warren Ingram.

Mr Price, Discovery and Aspen are hot investments right now. Here’s why…

Mr Price, Discovery and Aspen are hot investments right now. Here’s why…

Trofin fund manager Claudius Rostoll on why he believes these three companies are the best investments on the JSE right now.

South African pharma-giant Aspen Group making good money abroad

South African pharma-giant Aspen Group making good money abroad

Aspen Group released results saying the international business delivered 49% of gross revenue.

Popular articles
Fund manager lays criminal charges against former Steinhoff CEO Markus Jooste

Fund manager lays criminal charges against former Steinhoff CEO Markus Jooste

The Money Show’s Bruce Whitfield interviews Benguela Global Fund Managers Chief Investment Officer Zwelakhe Mnguni.

France exploring ways to assist City of Cape Town with water crisis

France exploring ways to assist City of Cape Town with water crisis

Xanthea Limberg says no formal agreement has been reached but it looks forward to talks and learning more from France.

'ANC may split if Dlamini-Zuma is elected leader'

'ANC may split if Dlamini-Zuma is elected leader'

Political analyst Dr Somadoda Fikeni sat down with Ray White to discuss the future of the ANC.

'This puts pressure on Jacob Zuma to vacate office earlier'

'This puts pressure on Jacob Zuma to vacate office earlier'

The Money Show’s Bruce Whitfield interviews Daniel Silke, Political Economy Analyst at Political Futures Consultancy.

Predictably awesome new Nando's ad reminds South Africans ‘we can fix our sh$t’

Predictably awesome new Nando's ad reminds South Africans ‘we can fix our sh$t’

Watch the Guptas pack their bags and run in Nando's inspiring new advertisement.